The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden

Acta Dermato-Venereologica

Volumn 85, Issue 2, 2005, Pages 164-166

  Linde, Ylva ^a   Harper, Pauline ^b   Floderus, Ylva ^b   Ros, Anne Marie ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Familial; Hepatitis C infection; Porphyria cutanea tarda; Prevalence; Sporadic

Indexed keywords

UROPORPHYRINOGEN DECARBOXYLASE;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PORPHYRIA CUTANEA TARDA; PREVALENCE; PRIORITY JOURNAL; SWEDEN;

EID: 16444364582     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.1080/00015550410023518     Document Type: Article

References (20)

1. Harper P, Thunell S, Hultcrantz R, Ros AM, Wennersten G. Porphyria cutanea tarda is the most common type of porphyria. Medical control is a team work. Läkartidningen 1998; 95: 3195-3199 (in Swedish).
2. Elder GH. Porphyria cutanea tarda. Semin Liver Dis 1998; 18: 67-75.
3. Thunell S, Harper P. Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda - suggestions for a handling programme. Scand J Clin Lab Invest 2000; 60: 561-579.
4. Fargion S, Piperno A, Capellini MD, Sampietro M, Fracanzani AL, Romano R. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992; 16: 1322-1326.
5. DeCastro M, Sánchez J, Herrera JF, Cháves A, Durán R, Garcia-Buey L. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 1993; 17: 551-557.
6. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993; 341: 788-789.
7. Lacour JP, Bodokh I, Castanet J, Bekri S, Ortonne JP. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993; 128: 121-123.
8. Lamoril J, Andant C, Bogard C, Puy H, Gouya L, Pawlotsky JM. Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda. Hepatology 1998; 27: 848-852.
9. Stölzel U, Köstler E, Koszka C, Stöffler-Meilicke M, Schuppan D, Somasundaram R. Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 1995; 21: 1500-1503.
10. Murphy A, Dooley S, Hillary IB, Murphy GM. HCV infection in porphyria cutanea tarda. Lancet 1993; 341: 1534-1535.
11. Bygum A, Christiansen L, Petersen NE, Horder M, Thomsen K, Brandrup F. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status. Acta Derm Venereol 2003; 83: 115-120.
12. Elder GH, Wyvill PC. Measurement of uroporphyrinogen decarboxylase using porphyrinogens prepared by chemical reduction. Enzyme 1982; 28: 186-195.
13. De Verneuil H, Sassa S, Kappas A. Purification and properties of uroporphyrinogen decarboxylase from human erythrocytes. A single enzyme catalyzing the four sequential decarboxylations of uroporphyrinogens I and III. J Biol Chem 1983; 258: 2454-2460.
14. Bonkovsky HL, Mehta S. Hepatitis C: a review and update. J Am Acad Dermatol 2001; 44: 159-182.
15. Treatment of chronic hepatitis C infection in adults and children. Information from the Medical Products Agency 1999; 6: 5-11 (in Swedish).
16. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 1998; 27: 1661-1669.
17. O'Reilly FM, Darby C, Fogarty J, O'Moore R, Courtney MG, O'Connor J. Porphyrin metabolism in hepatitis C infection. Photodermatol Photoimmunol Photomed 1996; 12: 31-33.
18. Lundvall O. The effect of phlebotomy therapy in porphyria cutanea tarda. Its relation to the phlebotomy-induced reduction of iron stores. Acta Med Scand 1971; 189: 33-49.
19. Roberts AG, Whatley SD, Nicklin S, Worwood M, Pointon JJ, Stone C. The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda. Hepatology 1997; 25: 159-161.
20. Harper P, Floderus Y, Holmström P, Eggertsen G, Gåfvels M. Enrichment of HFE mutations in Swedish patients with familial and sporadic form of porphyria cutanea tarda. J Intern Med 2004; 255: 684-687.